Eldepryl Tablets Dosage
Generic name: selegiline hydrochloride
Dosage form: tablet
This dosage information does not include all the information needed to use Eldepryl Tablets safely and effectively. See full prescribing information for Eldepryl Tablets.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
ELDEPRYL is intended for administration to Parkinsonian patients receiving levodopa/carbidopa therapy who demonstrate a deteriorating response to this treatment. The recommended regimen for the administration of ELDEPRYL are 10 mg per day administered as divided doses of 5 mg each taken at breakfast and lunch. There is no evidence that additional benefit will be obtained from the administration of higher doses. Moreover, higher doses should ordinarily be avoided because of the increased risk of side effects.
After two to three days of selegiline treatment, an attempt may be made to reduce the dose of levodopa/carbidopa. A reduction of 10 to 30% was achieved with the typical participant in the domestic placebo controlled trials who was assigned to selegiline treatment. Further reductions of levodopa/carbidopa may be possible during continued selegiline therapy.
- Eldepryl Side Effects
- Eldepryl Drug Interactions
- Eldepryl (selegiline) consumer information
- Eldepryl Capsules (selegiline hydrochloride) capsule dosage information
- Emsam (selegiline) transdermal patch dosage information
- Emsam (selegiline) consumer information
- Selegiline dosage information
- Zelapar (selegiline hydrochloride) orally disintegrating tablet dosage information
- Zelapar (selegiline) consumer information